NDC codes

FDA NDC Directory
Product NDC (as listed)73141-018Labeler and product segments. Claims need a package NDC.
Product NDC at billing width73141-0018Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
73141-018-0473141001804100 TABLET in 1 BOTTLE (73141-018-04)Marketed from Apr 8, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Guanfacine
Generic name (nonproprietary)
gaunfacine
Active ingredients
Guanfacine hydrochloride — 1 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 216828
Marketing start
Listing expires
Other FDA classes
Adrenergic alpha2-Agonists (Mechanism)
Identifiers
Product ID 73141-018_32c1e44a-6ccf-c3c7-e063-6394a90ad7fcSPL ID 32c1e44a-6ccf-c3c7-e063-6394a90ad7fcSPL set ID 00c3b4d2-fc4d-4e68-9157-eb29d927deafRxCUI 197745, 197746UNII PML56A160O
Pharmacologic class
Central alpha-2 Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N473141001804 followed by a unit qualifier and the quantity

Package 73141-0018-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Guanfacine Tablets, USP are indicated in the management of hypertension. Guanfacine hydrochloride may be given alone or in combination with other antihypertensive agents, especially thiazide-type diuretics.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216828

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216828
ProductStrengthForm · routeLabelerProduct NDC
GuanfacinegaunfacineGuanfacine hydrochloride 2 mg/1TabletOralA2A Integrated Pharmaceuticals73141-019
GuanfacinegaunfacineGuanfacine hydrochloride 1 mg/1TabletOrali3 Pharmaceuticals, LLC72319-018
GuanfacinegaunfacineGuanfacine hydrochloride 2 mg/1TabletOrali3 Pharmaceuticals, LLC72319-019
GuanfacinegaunfacineGuanfacine hydrochloride 2 mg/1TabletOralREMEDYREPACK INC.70518-4564

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in